Morgan Stanley&CoLLC

Rule 38.5 - ALLERGAN PLC

RNS Number : 0464J
Morgan Stanley & Co. LLC
14 August 2019
 

 

 FORM 38.5

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 38.5 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER  RULES, 2007 (AS AMENDED)

 

DEALINGS BY CONNECTED EXEMPT MARKET-MAKERS

 

1.             KEY INFORMATION

 Name of exempt market-maker

   Morgan Stanley & Co. LLC

 Company dealt in

   ALLERGAN PLC

 Class of relevant security to which the dealings being disclosed relate (Note 1)

  US$0.0001 ORDINARY SHARES

 Date of dealing

   13 AUGUST 2019

 

 

2.             DEALINGS (Note 2)

 

(a)           Purchases and sales

 Total number of relevant secuities accquired

 Highest price paid (Note 3)

 Lowest price paid (Note 3)

  429,708

 160.4600 USD

 158.5600 USD

 

 Total number of relevant secuities disposed

 Highest price paid (Note 3)

 Lowest price paid (Note 3)

  437,636

 160.4600 USD

 158.5600 USD

 

 

(b)           Derivatives transactions (other than options transactions)

 

 Product name, e.g. CFD

 Nature of transaction

                (Note 4)

 Number of relevant securities

                (Note 5)

 Price per unit

 N/A

 N/A

 N/A

 N/A

 

 

(c)            Options transactions in respect of existing relevant securities

 

i)           Writing, selling, purchasing or varying

 

 Product name, eg call option

 Writing, selling, purchasing, varying etc

 Number of securities to which the option relates (Note 5)

 Exercise Price

 Type, e.g American, European etc

 Expiry Date

 Option money paid/received per unit (Note 3)

 CALL

 PURCHASE

 100

 160.0000

A

 16/08/2019

 0.8000 USD

 CALL

 PURCHASE

 100

 160.0000

A

 16/08/2019

 0.8000 USD

 CALL

 PURCHASE

 100

 162.5000

A

 30/08/2019

 1.0600 USD

 CALL

 PURCHASE

 100

 162.5000

A

 30/08/2019

 1.0600 USD

 CALL

 PURCHASE

 800

 180.0000

A

 17/01/2020

 1.1500 USD

 CALL

 PURCHASE

 2,400

 170.0000

A

 17/01/2020

 3.8000 USD

 CALL

 PURCHASE

 2,300

 170.0000

A

 17/01/2020

 3.8500 USD

 CALL

 PURCHASE

 800

 170.0000

A

 17/01/2020

 3.8500 USD

 CALL

 PURCHASE

 400

 170.0000

A

 17/01/2020

 3.9000 USD

 CALL

 PURCHASE

 5,700

 170.0000

A

 17/01/2020

 3.9000 USD

 CALL

 PURCHASE

 1,600

 170.0000

A

 17/01/2020

 3.9000 USD

 CALL

 PURCHASE

 3,400

 170.0000

A

 17/01/2020

 3.9000 USD

 CALL

 PURCHASE

 300

 170.0000

A

 17/01/2020

 3.9500 USD

 CALL

 PURCHASE

 2,600

 170.0000

A

 17/01/2020

 3.9500 USD

 CALL

 PURCHASE

 1,600

 170.0000

A

 17/01/2020

 3.9500 USD

 CALL

 PURCHASE

 200

 170.0000

A

 17/01/2020

 4.0000 USD

 CALL

 PURCHASE

 100

 165.0000

A

 17/01/2020

 5.9400 USD

 CALL

 PURCHASE

 1,500

 165.0000

A

 17/01/2020

 5.9500 USD

 CALL

 PURCHASE

 2,100

 160.0000

A

 17/01/2020

 8.6000 USD

 PUT

 PURCHASE

 400

 170.0000

A

 17/01/2020

 13.2000 USD

 CALL

 SALE

 100

 165.0000

A

 17/01/2020

 5.8900 USD

 CALL

 SALE

 2,500

 150.0000

A

 19/06/2020

 18.5500 USD

 CALL

 SALE

 2,500

 150.0000

A

 19/06/2020

 18.5500 USD

 CALL

 SALE

 1,000

 150.0000

A

 19/06/2020

 18.5800 USD

 CALL

 SALE

 1,000

 150.0000

A

 19/06/2020

 18.5800 USD

 CALL

 SALE

 2,000

 150.0000

A

 19/06/2020

 18.6100 USD

 CALL

 SALE

 2,000

 150.0000

A

 19/06/2020

 18.6100 USD

 

(ii) Exercising

 

 Product name, eg call option

 Number of securities

 Exercise price per unit (Note 3)

 PUT SHORT

 200

 170.0000  USD

 

 

3. OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

Full Details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

 

 

 

 

 

 

 

 

 Date of disclosure

 14 AUGUST 2019

 Contact Name

Craig Horsley

 Telephone Number

+44(141) 245 7736

 Name of offeree/offeror with which connected

ABBVIE INC.

Nature of connection (Note 6)

Advisory

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
ISELIFEATAISLIA